A Closer Look At Acellular Dermal Matrices For Chronic Diabetic Foot Ulcers
- Volume 25 - Issue 11 - November 2012
- 5212 reads
- 0 comments
1. Centers for Disease Control and Prevention. 2011. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, 2011.
2. Brigido SA. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J. 2006;3(3):
3. Steinberg JS, Weber B, Kim PJ. 2009. Bioengineered alternative tissues for the surgical management of diabetic foot ulceration In: T. Zgonis ed. 2009. Surgical Reconstruction of the Diabetic Foot and Ankle, Ch. 9, Lippincott Williams and Wilkins, Philadelphia, PA, 2009, pp. 100-115.
4. Life Cell Corporation. Alloderm defined. LifeCell Corporation; Branchburg, NJ, 2004.
5. Lin HJ, Spoerke N, Deveney C, Martindale R. Reconstruction of complex abdominal wall hernias using acellular human dermal matrix: a single institute experience. Am J Surg. 2009;197(5):599-603; discussion 603.
6. Gaertner WB, Bonsack ME, Delaney JP. Experimental evaluation of four biologic prostheses for ventral hernia repair. J Gastrointest Surg. 2007;11(10):1275-85.
7. Winters CL, Brigido SA, Liden BA, et al. A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds. Advances in Skin and Wound Care. 2008;21(8):375-381.
8. Reyzelman A, Crews RT, Moore JC, et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomized, multicentre study. Int Wound J. 2009;6(3):196-208.
9. Rice A. Memoderm Acellular Dermal Matrix: Used to treat a complex diabetic foot wound. Data on file, Stryker, 2011.
10. Rice A. Memoderm Acellular Dermal Matrix: Used to treat transmetatarsal amputation. Data on file, Stryker, 2011.
11. Solana Surgical. TenSIXTM acellular dermal matrix. Solana Surgical; Memphis, TN, 2012.
12. Von Woedtke T, Kramer A. The limits of sterility assurance. GMS Krankenhhyg Interdiszip. 2008;3(3):19.
13. Srun SW, Nissen BJ, Bryans TD, Bonjean M. Medical devices SALs and surgical site infections: a mathematical model. Biomed Instrum Technol. 2012;46(3):230-237.
For further reading, see “Acellular Orthobiologics: Can They Improve Wound Healing?” in the September 2008 issue of Podiatry Today. To access the archives, visit www.podiatrytoday.com.